BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20181017T210000Z
DTEND:20181018T004500Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Boston's Life Science Disruptors
DESCRIPTION:Innovation is moving fast in biotech\, and look no further than some of Boston's latest emerging companies for proof. Beam Therapeutics\, for instance\, is taking CRISPR gene editing to the next level. Celsius Therapeutics is using machine learning algorithms to drill down into the genomic blueprint of single cells in search of a better understanding of why various diseases begin. And Arrakis Therapeutics is one of several new companies trying to target disease-causing RNA molecules with chemical drugs. How do disruptive visions like these come together and take shape within a company? How do their founders and investors turn these ideas into a business? And most importantly\, how will their work impact the lives and health of patients?\n\n \n\nJoin Xconomy for this unique event featuring candid stories from some of New England's most radical biotech company leaders\, founders\, and VC backers out to change the game in life sciences.
X-ALT-DESC;FMTTYPE=text/html:<span style="color:#4B5B72"><span style="font-family:georgia\,serif"><span style="font-size:15.0pt">Innovation is moving fast in biotech\, and look no further than some of Boston&rsquo\;s latest emerging companies for proof. Beam Therapeutics\, for instance\, is taking CRISPR gene editing to the next level. Celsius Therapeutics is using machine learning algorithms to drill down into the genomic blueprint of single cells in search of a better understanding of why various diseases begin. And Arrakis Therapeutics is one of several new companies trying to target disease-causing RNA molecules with chemical drugs. How do disruptive visions like these come together and take shape within a company? How do their founders and investors turn these ideas into a business? And most importantly\, how will their work impact the lives and health of patients?</span></span></span><br />\n&nbsp\;<br />\n<span style="color:#4B5B72"><span style="font-family:helvetica neue"><span style="font-size:13.5pt">Join Xconomy for this unique event featuring candid stories from some of New England&#39\;s most radical biotech company leaders\, founders\, and VC&nbsp\;backers out to change the game in life sciences.</span></span></span>
LOCATION:Koch Institute for Integrative Cancer Research (500 Main St\, Cambridge\, MA 02142).
UID:e.2779.3426
SEQUENCE:3
DTSTAMP:20260513T061114Z
URL:https://members.bostonchamber.com/events/details/boston-s-life-science-disruptors-3426
END:VEVENT

END:VCALENDAR